Nadine Ritter

Latest from Nadine Ritter

Stability Testing: Monitoring Biological Product Quality Over Time
QA/QC
Stability Testing: Monitoring Biological Product Quality Over TimeStability Testing: Monitoring Biological Product Quality Over Time
byCheryl Scott, Nadine Ritter
Mar 9, 2021
Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability
CMC Forums
Emerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product ComparabilityEmerging Strategies for Drug Product Comparability and Process Validation: Part 1 — Analytical Tools and Drug Product Comparability
byZahra Shahrokh, Andrew Weiskopfand 7 more
Mar 9, 2021

All from Nadine Ritter

Bioassay Evolution: Finding Best Practices for Biopharmaceutical Quality Systems
QA/QC
Bioassay Evolution: Finding Best Practices for Biopharmaceutical Quality Systems
Bioassay Evolution: Finding Best Practices for Biopharmaceutical Quality Systems
Feb 7, 2020
+2
byCheryl Scott, Laureen Littleand 2 more
Strategies for Successful Sample Transfer
QA/QC
Strategies for Successful Sample Transfer
Strategies for Successful Sample Transfer
Apr 17, 2017
+1
byMaribel Rios, S. Anne Montgomeryand 1 more
Science, Risks, and Regulations: Current Perspectives on Host Cell Protein Analysis and Control
CMC Forums
Science, Risks, and Regulations: Current Perspectives on Host Cell Protein Analysis and Control
Science, Risks, and Regulations: Current Perspectives on Host Cell Protein Analysis and Control
Sep 15, 2016
+8
byZahra Shahrokh, Dieter Schmalzingand 8 more
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Forums
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
CMC Strategy Forum Special Focus Series: Part 2 Product-Related Impurities, An Overview
Apr 12, 2016
+18
byCheryl Scott, Siddharth J. Advant, PhDand 18 more
Bridging Analytical Methods for Release and Stability Testing: Technical, Quality and Regulatory Considerations logo in a gray background | Bridging Analytical Methods for Release and Stability Testing: Technical, Quality and Regulatory Considerations
Product Characterization
Bridging Analytical Methods for Release and Stability Testing: Technical, Quality and Regulatory Considerations
Bridging Analytical Methods for Release and Stability Testing: Technical, Quality and Regulatory Considerations
Feb 4, 2016
+9
byNadine Ritter, Reb Russelland 9 more
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, Biosimilar Products: Scientific Principles, logo in a gray background | Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, Biosimilar Products: Scientific Principles,
Biosimilars
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, Biosimilar Products: Scientific Principles, Challenges, and Opportunities
Special Report on Assays, Test Methods, and Comparability The CMC Strategy Forum Series, Part 4, Biosimilar Products: Scientific Principles, Challenges, and Opportunities
Nov 17, 2015
+2
byAnthony Ridgway, PhD, Nadine Ritterand 2 more
Expanded Change Protocols: Benefits, Cost Considerations, and Regulatory Views
CMC Forums
Expanded Change Protocols: Benefits, Cost Considerations, and Regulatory Views
Expanded Change Protocols: Benefits, Cost Considerations, and Regulatory Views
Mar 10, 2015
+6
byNadine Ritter, Julia Edwardsand 6 more
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices logo in a gray background | Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Assays
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Reference Standards for Therapeutic Proteins: Current Regulatory and Scientific Best Practices
Mar 1, 2014
+3
byAnthony Mire- Sluis, Nadine Ritterand 3 more
Biosimilar Products
Biosimilars
Biosimilar Products
Biosimilar Products
Nov 1, 2013
+2
byAnthony Ridgway, PhD, Nadine Ritterand 2 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Register Now: Light Boxes and Beyond: Maximizing Confidence in Clone Selection Using the Beacon Optofluidic System
Insider News
See all
Mar 18 - Mar 21, 2025
SLASH TIME FROM BENCH TO BEDSIDE: Cutting-edge biomanufacturing for mAbs, vaccines, and advanced therapies. Bright ideas, bold science, and big innovations—delivering efficiency, precision, and quality through every phase of bioprocessing.
Learn More

Innovative Technology

Thermo Fisher Scientific peptones white paper
Sponsored Content
The Value of Peptones for Enhancing Biopharmaceutical Productivity
The Value of Peptones for Enhancing Biopharmaceutical Productivity

Jan 27, 2025

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe